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ATP loss is a prominent feature of cellular injury in- 
duced by oxidants or ischemia. How reduction of cellular 
ATP levels contributes to lethal injury is still poorly un- 
derstood. In this study we examined the ability of HzOz 
to inhibit in a dose-dependent manner the extrusion of 
fluorescent organic anions from bovine pulmonary artery 
endothelial cells. Extrusion of fluorescent organic anions 
was inhibited by probenecid, suggesting an organic anion 
transporter was involved. In experiments in which ATP 
levels in endothelial cells were varied by treatment with 
different degrees of metabolic inhibition, it was deter- 
mined that organic anion transport was ATP-dependent. 
H20z-induced inhibition of organic anion transport cor- 
related well with the oxidant’s effect on cellular ATP 
levels. Thus H,Oz-mediated inhibition of organic anion 
transport appears to be via depletion of ATP, a required 
substrate for the transport reaction. Inhibition of organic 
anion transport directly by probenecid or indirectly by 
metabolic inhibition with reduction of cellular ATP levels 
was correlated with similar reductions of short term vi- 
ability. This supports the hypothesis that inhibition of 
organic anion transport after oxidant exposure or during 
ischemia results from depletion of ATP and may signif- 
icantly contribute to cytotoxicity. 0 1992 Academic Press, Inc. 
Oxidants generated from the reduction of molecular 0, 
have been implicated as important mediators of toxic cel- 
lular injury in inflammation and after reperfusion of isch- 
emit tissues (1, 2). The toxicity of one of the most ubiq- 
uitous of these oxidants, hydrogen peroxide (H202), has 
been extensively studied. Exposure to Hz02 initiates a 
sequence of biochemical events which includes rapid ac- 
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tivation of the nuclear enzyme poly(ADP-ribose) poly- 
merase in association with DNA strand breakage (3-6); 
disruption of intracellular Ca2+ homeostasis (7, 8); acti- 
vation of the glutathione redox cycle (9); lipid peroxida- 
tion (10); inhibition of the glycolytic enzyme, glyceral- 
dehyde 3-phosphate dehydrogenase, and inhibition of 
mitochondrial ADP phosphorylation, with a resultant in- 
hibition of glucose-dependent ATP synthesis (11-13); and 
cytoskeletal alterations including oxidation of sulfhydryl 
groups in actin, induction of actin polymerization, an 
ATP-dependent disruption of visible microfilament or- 
ganization, and alteration of cellular morphology includ- 
ing membrane blebbing (14-20). 
The precise role which loss of ATP plays in HpOz-me- 
diated cytotoxicity is unclear (21). Recently we have 
demonstrated that significant improvement of short term 
viability of endothelial cells following H,O, exposure can 
be achieved by increasing ATP levels in association with 
glutamine administration (22,23). These short term ben- 
efits are not borne out over 24 h, however, suggesting that 
other mechanisms may come into play in regard to longer 
term cell survival after H,O, injury (23). Some of the toxic 
effects of HzOn on cells, such as disruption of visible mi- 
crofilament organization and loss of intracellular Ca” 
homeostasis, appear to be at least in part a result of the 
effect of H202 on ATP levels within the injured cells (7, 
8, 15, 16). In endothelial cells, intracellular Ca2’ homeo- 
stasis is remarkably stable in response to large reductions 
of cellular ATP induced by metabolic inhibitors or H,O, 
(8). Although H202 concentrations of approximately 500 
PM can significantly reduce ATP levels and produce dra- 
matic ATP-dependent disruption of visible microfilament 
organization, only concentrations of H202 > 5 mM alter 
Ca2+ homeostasis and induce Ca2+-dependent microtubule 
depolymerization in endothelial cells (8). Similarly, only 
when ATP loss from metabolic inhibition is combined 
with exposure to Ca2+ ionophore is there a sustained ele- 
vation of intracellular Ca2+ in these cells (8). 
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In earlier work (7) we noted that cellular exposure to 
low millimolar concentrations of HzOz was associated with 
an inhibition of extrusion of the fluorescent organic anion 
dye, Quin 2, from the injured cells. Jacobs et al. (24) have 
noted a similar phenomenon in which the extrusion of 
fura- from rabbit proximal tubules was inhibited after 
exposure to metabolic inhibition. Recently, it has been 
demonstrated that macrophages contain a probenecid- 
inhibitable organic anion transporter (25) which also ap- 
pears to be present in granulocytes (26). This observation 
has made it possible to use probenecid as a means of pre- 
venting rapid extrusion of fluorescent organic anion dyes 
during physiologic studies of cellular function, although 
it has been noted that exposure to probenecid itself for 
several hours can be toxic to cells (25, 27). 
In this study we present data demonstrating that bovine 
pulmonary artery endothelial cells possess a probenecid- 
inhibitable organic anion transporter and that organic 
anion transport in endothelial cells can also be inhibited 
by HzOz exposure. Furthermore, we demonstrate that or- 
ganic anion transport is ATP-dependent and that the in- 
hibition of organic anion transport by HzOz is correlated 
with HzOz effects on endothelial ATP levels. Finally, we 
hypothesize that inhibition of organic anion transport in 
endothelial cells by HzOz may be an important mechanism 
of ATP-dependent rapid cell death. 
MATERIALS AND METHODS 
Cells and culture. Bovine pulmonary artery endothelial cells used in 
these experiments were from the National Institute of Aging, Aging Cell 
Culture Repository (No. AG2791A; Camden, NJ). They were cultured 
at 37°C under 5% C02/95% air in medium RPM1 1640 supplemented 
with 2 mM glutamine (GIBCO, Grand Island, NY), 10% fetal bovine 
serum (Whittaker, M.A. Bioproducts, Walkersville, MD), 100 r/ml 
penicillin, and 100 pg/ml streptomycin (GIBCO), and 10 mM Hepes for 
additional buffering capacity. Cells were grown in 75- or 150~cm* flasks 
(Corning, Corning, NY). Cells from passages 4 to 10 were used for these 
experiments. Cells were suspended after a IO- to 15min exposure to 
trypsin (0.05%)-EDTA (0.02%) (Sigma, St. Louis, MO). Experiments 
were carried out using modified Geys buffer (MGB)’ containing 147 mM 
NaCl, 5 mM KCl, 1.9 mM KHzPOl, 1.1 mM Na2HP04, 0.3 mM MgS04, 
1 mM MgCl*, 10 mM Hepes, 1.5 mM CaCl,, and 5.5 mM glucose at pH 
7.4. Under some experimental conditions, glucose was deleted from the 
buffer or glutamine (2 mM) was added. 
Cellular loading with organic anion fluorophores and assay of organic 
anion transport. Endothelial cells (1 X lo7 cells/ml) in MGB were 
warmed to 37°C for 5 min. The acetoxymethyl esters of Quin 2, Quin 
2-AM, or of 2’,7’-bis-(2carboxyethyl)-5(and -6) carboxyfluorescein, 
BCECF-AM (Molecular Probes, Inc., Junction City, OR), were prepared 
as 5 and 1 mM stock solutions in DMSO, respectively, and were added 
to the cells with stirring over 1 min to give final concentrations of 50 
pM Quin 2-AM and 5 @M BCECF-AM. The cell suspension in a 50-ml 
centrifuge tube was then placed on a nutator (rotational stirring device) 
for 25 min at 37°C. At the end of the 25-min labeling period, the cells 
were washed with an excess of MGB and centrifuged at 1500 RPM for 
‘Abbreviations used: MGB, modified Geys buffer; AM, acetoxymethyl; 
BCECF, 2’,7’-bis-(2-carboxyethyl)-5(and -6) carboxyfluorescein; DMSO, 
dimethyl sulfoxide; TX-100, Triton X-100. 
5 min, and the pellet was resuspended in MGB at a concentration of 2 
X lo6 cells/ml and placed on ice until ready for use. 
Prior to the extrusion assay, labeled cells were warmed for 5 min at 
37°C. At time zero, a bolus of Hz02, oligomycin, or KCN was added. 
For probenecid samples, cells were centrifuged after 5 min of warming 
to 37°C and then resuspended in warm MGB containing the appropriate 
concentration of probenecid. If the sample was to be depleted of glucose, 
the cells were washed in cold MGB without added glucose twice prior 
to the 5-min period of warming. In some experiments 11 mM P-deoxy- 
glucose was also present in the glucose-free MGB during the extrusion 
assay. In samples depleted of glucose for 4 h prior to assay, unlabeled 
cells were incubated in glucose-free MGB for 3.5 h at 37°C and Quin 2 
was then added to the sample for the last 25 min of the 4-h incubation 
being loaded as described above using glucose-free MGB for the wash 
steps and for the incubation media during the assay. Glucose depletion 
for 4 h did not alter the efficiency of Quin 2 loading by the cells (data 
not shown). 
At each time point during the 2-h time course of the extrusion assay, 
a 0.5-ml sample of the cell suspension was removed and centrifuged 
quickly (30 s) in a microcentrifuge. The supernatant was removed and 
added to a cuvette containing 1.5 ml of MGB, and the fluorescence was 
read on an SLM 8000C spectrofluorometer (340 nm, excitation wave- 
length, and 520 nm, emission wavelength, for Quin 2; 490 nm, excitation 
wavelength, and 520 nm, emission wavelength, for BCECF). Intracellular 
fluorescence due to Quin 2 or BCECF was quantitated in the same man- 
ner after resuspension of the pellet in 2 ml of MGB to which a final 
concentration of 0.075% Triton X-100 (TX-100) was added, thus making 
it possible to measure the fluorescence of the intracellular fluorophore 
under essentially the same pH and ionic conditions as for the fluorophore 
present in the supernatant. No further increase in fluorescence of either 
fluorophore was detected upon addition of more TX-100, confirming 
that complete lysis of the cells had occurred. For each time point, the 
total fluorescence was determined as the sum of the fluorescence of the 
supernatant plus the fluorescence of the extracted pellet. The percentage 
of cell-associated organic anion fluorophore was determined from the 
relationship (fluorescence of the extracted cell pellet/total fluorescence 
of the sample) X 100%. Total fluorescence for individual samples 
throughout the 2-h time course remained constant (data not shown). 
ATP measurements. Measurement of ATP in the endothelial cells 
at each time point during the assay of organic anion transport was 
performed as previously reported using the luciferin-luciferase assay 
(17, 28). 
Viability measurements. Cellular viability was determined by the 
ability of the endothelial cells to exclude trypan blue. Fifty microliters 
of cell suspension was incubated briefly with 12 ~1 0.1% trypan blue in 
0.9% NaCl (final concentration approximately 0.02%). The number of 
cells excluding trypan blue out of 100 cells counted on a hemocytometer 
was expressed as the percentage of viable cells. 
Statistics. Data are presented as the mean + SD. Statistical com- 
parisons were made using repeated measures analysis of variance with 
P < 0.05 being considered significant. Correlation of cell-associated or- 
ganic anion fluorophore with ATP levels was determined by least squares 
linear regression. 
RESULTS 
Probenecid-Sensitive Transport of Quin 2 by Endothelial 
Cells 
Endothelial cells loaded with Quin 2 were incubated at 
37°C in the presence of O-5 mM probenecid over a 2-h 
time course. The percentage of cell-associated Quin 2 was 
determined immediately after addition of probenecid and 
at 30, 60, and 120 min of exposure to the drug. Progres- 
sively greater degrees of inhibition of Quin 2 extrusion 
from endothelial cells were seen with increasing concen- 
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FIG. 1. The effect of probenecid on the extrusion of Quin 2 from 
endothelial cells. Cells were loaded with Quin 2 as described under Ma- 
terials and Methods. At time zero, cells were resuspended in buffer con- 
taining probenecid and cell associated Quin 2 was measured at 37°C 
over a 2-h time course (see Materials and Methods for details). Each 
data point represents the mean -C SD of N = 4-12 separate determi- 
nations. 
trations of probenecid (Fig. 1). Thus, extrusion of Quin 
2 from endothelial cells occurred via a probenecid-inhib- 
itable mechanism, presumably via an organic anion 
transporter as has been described for other cells (25, 26). 
HzOz-Induced Inhibition of Quin 2 Transport by 
Endothelial Cells 
HzOz exposure induced a dose-dependent inhibition of 
Quin 2 transport out of endothelial cells over a 2-h time 
course (Fig. 2). Whereas approximately 50% of cell-as- 
sociated Quin 2 was lost from control cells after 2 h, pro- 
gressively greater amounts of the fluorophore were re- 
tained within the cells after exposure to increasing 
concentrations of HzOz (Fig. 2). Concentrations of HzOa 
2 1 mM were associated with only a small amount of Quin 
2 extrusion, comparable to that seen with probenecid 
treatment (Fig. 1). Significant (P = 0.0152) inhibition of 
Quin 2 extrusion over the 2-h time course was seen with 
concentrations of HzOz as low as 500 pM. 
ATP and the Activity of the Probenecid-Sensitive Anion 
Transporter 
Since the greatest inhibition of Quin 2 transport from 
endothelial cells after Hz02 exposure occurred with con- 
centrations of the oxidant previously associated with 
substantial reductions of cellular ATP levels (8, 22, 23), 
we examined the effect on organic anion transport of dif- 
ferent conditions which could decrease cellular ATP levels 
independent of oxidant exposure (see Materials and 
Methods for details). Figure 3 demonstrates the effect of 
different types of metabolic inhibition on the transport 
of Quin 2 out of endothelial cells over a 2-h time course. 
It becomes apparent that when the data in Fig. 3 are com- 
- 100@4H 202 
* 250vM H 0 
22 
- 50011MH202 
* 1mMH 0 
22 
--t 25mMH202 
FIG. 2. The effect of H,O, exposure on the extrusion of Quin 2 from 
endothelial cells. Cells were loaded with Quin 2 and at time zero a bolus 
of Hz02 was added and cell associated Quin 2 was measured over a 2-h 
time course. Each data point represents the mean + SD of N = 4-12 
separate determinations. 
pared with ATP levels measured under the same condi- 
tions over the 2-h time course (Fig. 4), progressively 
greater degrees of metabolic inhibition and reduction of 
ATP levels are associated with greater inhibition of 
transport of the fluorophore out of the cells. 
Recently, we have demonstrated the ability to signifi- 
cantly improve ATP levels in endothelial cells injured by 
HzOz by supplementation of the cells with the amino acid 
glutamine (22, 23). To demonstrate more directly that 
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FIG. 3. The effect of metabolic inhibition on the extrusion of Quin 
2 from endothelial cells. Cells were loaded with Quin 2 and then exposed 
to the following conditions: (1) resuspension in MGB plus glucose to 
which 650 nM oligomycin (oligo) or 4 mM KCN was added at time zero; 
(2) resuspension in MGB minus glucose containing 11 mM 2-deoxyglu- 
case (2-DOG) to which 650 nM oligomycin was added at time zero; (3) 
resuspension in MGB minus glucose to which 4 mM KCN was added at 
time zero; (4) the minus glucose 4-h sample was depleted of glucose for 
3.5 h prior to loading with Quin 2 under glucose-depleted conditions. 
The cells remained in glucose-free buffer throughout the assay. Each 
data point represents the mean f SD of N = 3-12 separate determi- 
nations. 
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To determine whether HzOz could also inhibit proben- 
ecid-sensitive transnort of other organic anions from en- 
dothelial cells, extrusion of the fluorophore, BCECF, after 
endothelial exposure to HaOz or probenecid was monitored 
over a 2-h time course (Fig. 6). BCECF was extruded from 
control endothelial cells to a similar extent as Quin 2. 
Both probenecid (5 mM) and HzOz (2.5 mM) inhibited 
extrusion of BCECF from the cells (Fig. 6) although not 
as effectively as they inhibited Quin 2 extrusion. When 
ATP levels in the cells had been reduced substantially, 
at time points > 30 min, the rate of loss of BCECF from 
cells exposed to HsOB began to slow down (Fig. 7). 
FIG. 4. The effect of metabolic inhibition on ATP levels in endothelial 
cells. Control ATP levels over the 2-h time course ranged from 8.93 + 
4.39 to 6.71 + 3.05 nmol/2 X 10s cells, N = 11 and 13, respectively. 
Conditions were the same as for Fig. 3. Each bar represents the mean 
f SD of N = 4-8 separate determinations. 
Hz02 effects on organic anion transport in endothelial 
cells were in proportion to H,Oz-induced loss of cellular 
ATP we examined the effect of glutamine supplementa- 
tion during HzOz exposure on organic anion transport in 
the cells (Fig. 5A). Exposure to 5 mM HzOz in the presence 
of 2 mM glutamine was associated with a significant (P 
= 0.0002) increase in the rate of organic anion transport 
compared to that of HzOz-injured cells without glutamine 
present. This correlated well with a glutamine-associated 
increase in ATP levels in the injured cells (Fig. 5B) which 
was also significant (P = 0.0225). Treatment of H202- 
injured cells with glutamine did not completely restore 
ATP or organic anion transport to the levels seen in con- 
trol cells. Glutamine did not significantly alter ATP levels 
or organic anion transport in control cells. 
A 
Correlation of Cellular ATP Levels and Endothelial 
Organic Anion Transport 
When ATP levels in endothelial cells measured at 120 
min under the different experimental conditions present 
in Figs. 2 and 3 were correlated with the percentage of 
cell associated Quin 2, there was a highly significant (P 
= 0.0003) correlation (r = -0.8828) between reduction of 
cellular ATP levels and retention of the fluorophore by 
the cells (Fig. 8). These data were consistent with the 
hypothesis that reduction of ATP levels in H,Oz-injured 
endothelial cells accounted for the inhibition of organic 
anion transport. 
Inhibition of Organic Anion Transport and Endothelial 
Cell Injury 
Probenecid has been reported to exert toxic effects on 
cells (25). It has also been unclear what precise role ATP 
reductions may play in oxidant-mediated cell killing (21, 
23). We next compared the effect two different means of 
0 30 60 120 
Time In Minutes 
H control 
H Control + Gin 
q mli*o* 
q SmM H20z + Gin 
FIG. 5. The effect of glutamine supplementation on the extrusion of Quin 2 and ATP levels in endothelial cells exposed to H202. (A) Time 
course of Quin 2 extrusion from endothelial cells. Each data point represents the mean + SD of N = 7 or 8 separate determinations. Glutamine 
(Gln) at a final concentration of 2 mM was added at the time of HzOz addition. (B) Time course of ATP levels in endothelial cells. Each bar 
represents the mean + SD of N = 6 or 7 separate determinations. 
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FIG. 6. The effect of probenecid and Hz02 on the extrusion of BCECF 
from endothelial cells. Cells were loaded with BCECF and at time zero 
probenecid (final concentration 5 mM) or H202 (final concentration 2.5 
mM) were added and cell-associated BCECF was measured over a 2-h 
time course. Each data point represents the mean _+ SD of N = 5 separate 
determinations. 
producing a comparable degree of anion transport inhi- 
bition had on short term viability of the endothelial cells. 
Exposure of endothelial cells to 5 mM probenecid or 650 
nM oligomycin plus 11 mM 2-deoxyglucose produced very 
similar patterns of inhibition of the transport of Quin 2 
out of the cells (see Figs. 1 and 3). In contrast to this, 
ATP levels were quite different over the same time course 
in response to the two treatments. Metabolic inhibition 
with oligomycin and 2-deoxyglucose produced a dramatic 
reduction of ATP levels to t5% of control levels after 30 
min (Fig. 4), whereas probenecid did not produce any sig- 
nificant early effect on ATP levels (Fig. 7) or at later time 
I: --t Control --o- 5mM Probenecld 
f- 25mMH202 
Time In Minutes 
FIG. 7. The effect of probenecid and H,Oz on ATP levels in endothelial 
cells from the experiment in Fig. 6. Conditions were the same as for 
Fig. 6. Each data point represents the mean f SD of N = 4 or 5 separate 
determinations. 
E -z 20. 
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Percent Cell Assocmted Ouln 2 
FIG. 8. Correlation of cell associated Quin 2 with cellular ATP levels 
at the end of the 2-h assay. Data has been taken from the 120 min time 
point of Figs. 2-4. Circle, control; triangles, H,O, exposure; squares, 
metabolic inhibition. ATP data presented for HzO,-treated samples (not 
shown in Figs. 2-4) represent the mean of N = 4-8 separate determi- 
nations. 
points (control = 3.18 + 0.68 nmol/2 X 10” cells vs pro- 
benecid = 2.81 4 1.14 nmol/2 X lo6 cells at 6 h; N = 3). 
Short term viability measured over a 6-h time course 
showed a progressive time-dependent reduction of via- 
bility (P < 0.01) under the two conditions in which anion 
transport was inhibited (Fig. 9). The difference between 
the effect of probenecid and the metabolic inhibitors on 
endothelial viability was not significantly different over 
the time course. These observations support the concept 
that inhibition of organic anion transport associated with 
reduction of ATP levels in endothelial cells after H202 
exposure may play an important role in the mechanism 
of H,O,-induced cytotoxicity. 
I3 Control 
H 5mM Probenecld 
Q Oligoglu+Z-DOG 
2 4 6 
Time In Hours 
FIG. 9. The effect of conditions which inhibit organic anion transport 
on endothelial cell viability (trypan blue exclusion). Each bar represents 
the mean t SD of N = 6-10 separate determinations. 
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DISCUSSION 
Using two different organic anion fluorophores, we have 
demonstrated that a probenecid-inhibitable organic anion 
transporter is present within bovine pulmonary artery 
endothelial cells. HzOz exposure produced a dose-depen- 
dent inhibition of organic anion transport. Progressively 
greater degrees of metabolic inhibition (with associated 
ATP loss) were also correlated with inhibition of fluor- 
ophore extrusion from the cells. In cells treated with HaOa 
or metabolic inhibition, retention of cell-associated flu- 
orophore at the end of the assay period was highly cor- 
related with reduction of cellular ATP levels. Experiments 
with glutamine supplementation during HzO, exposure 
also demonstrated in a more direct fashion that HzOz in- 
hibits organic anion transport in endothelial cells via its 
effect on cellular ATP levels. 
It is interesting that with either fluorophore the degree 
to which probenecid treatment inhibited dye extrusion 
was similar to the effect of H,Oa. Thus, when probenecid 
produced nearly complete inhibition of Quin 2 extrusion 
so did H202, whereas similar dosages of probenecid and 
HzOz only partially inhibited BCECF extrusion, suggest- 
ing that BCECF may also be extruded from endothelial 
cells by another mechanism. HzO,-mediated inhibition of 
BCECF extrusion also became more prominent at time 
points when ATP levels in the injured cells were quite 
low (Fig. 7), lending further support to the concept that 
the HzO,-mediated inhibition of organic anion transport 
was a result of reduction of cellular ATP levels. 
Varani et al. (21) have recently been able to dissociate 
ATP loss from lethal oxidant injury of endothelial cells. 
We have been able to demonstrate a significant ATP- 
related improvement in short term (6 h) endothelial cell 
viability after oxidant exposure with glutamine supple- 
mentation (23). Glutamine supplementation with the as- 
sociated increase in cellular ATP levels did not improve 
later survival data at 24 h, however (23). When compared 
with previously published data, these experiments have 
demonstrated that organic anion transport is more sen- 
sitive to ATP loss from metabolic inhibition or HzOz ex- 
posure than is intracellular Ca2+ homeostasis (8). Al- 
though inhibition of organic anion transport was 
demonstrable with H20, concentrations > 500 PM, a lo- 
fold increase in the concentration of the oxidant was 
needed to cause an elevation of intracellular Ca2+ in en- 
dothelial cells (8). This implies that ATP-dependent cel- 
lular functions have a differential sensitivity to ATP loss 
and that anion transport may be one of the more sensitive 
ones. Thus, changes in ATP levels following acute ex- 
posure to oxidants may modulate the rate and perhaps 
manner of cell killing, although a separate ATP-indepen- 
dent mechanism of cytotoxicity secondary to oxidants 
exists. 
We hypothesized that inhibition of organic anion 
transport within endothelial cells in association with ATP 
loss due to oxidant exposure or metabolic inhibition may 
contribute to the toxicity seen accompanying acute ATP 
loss in these models of cell injury. We examined two dif- 
ferent conditions which produced similar degrees of in- 
hibition of organic anion transport. These conditions 
(probenecid and metabolic inhibition) produced similar 
reductions of cellular viability over a 6-h time course (Fig. 
9). This was consistent with the hypothesis that inhibition 
of organic anion transport in association with ATP loss 
may be modulating oxidant-mediated cytotoxicity and 
also be an important contributor to cell injury in ischemia 
when ATP levels may also be significantly reduced. A 
defect in cellular lactate export by the organic anion 
transporter has been postulated to account for skeletal 
muscle injury following exercise in an otherwise healthy 
subject (29). Also, eicosanoids have been demonstrated 
to be transported by similar, probenecid-inhibitable and 
energy-dependent mechanisms (30). Defective organic 
anion transport by endothelial cells during ischemia or 
after oxidant exposure might inhibit the cell’s ability to 
participate in the inflammatory response (e.g., by blocking 
export of eicosanoid mediators) in addition to causing the 
accumulation of organic anions like lactate which may 
exacerbate the injury. 
In summary, we have demonstrated that bovine pul- 
monary artery endothelial cells possess a probenecid-sen- 
sitive organic anion transporter. Organic anion transport 
in the cells is ATP-dependent and Hz02 inhibits organic 
anion transport by depleting ATP. We propose that in- 
hibition of organic anion transport may represent a novel 
mechanism by which oxidants can induce cellular injury 
and that it may be particularly relevant for understanding 
ischemic injury. 
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